Alpha-1 Antitrypsin Protects Against Cisplatin-Induced Acute Kidney Injury by Restoring Redox and Mitochondrial Homeostasis
Biomolecules · 2026
DOI: 10.3390/biom16020222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Mina Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, D…. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Mitochondria, alpha 1-Antitrypsin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyungpook National University Hospital, Biomedical Research Institute grant, Kyungpook National University Hospital.
Abstract (Originalsprache)
Cisplatin is an effective chemotherapeutic agent, yet its clinical utility is limited by dose-dependent nephrotoxicity. Alpha-1 antitrypsin (AAT) has cytoprotective, anti-inflammatory, and antiapoptotic properties, but its therapeutic potential in cisplatin-induced acute kidney injury (AKI) remains unclear. A murine cisplatin–AKI model was used to evaluate whether AAT (80 mg/kg) ameliorates renal injury. Renal function, oxidative stress, NADPH oxidase (NOX) isoforms, mitochondrial metabolism, inflammatory mediators, apoptosis, and fibrosis-related markers were assessed using biochemical, histological, immunohistochemical, and Western blot analyses. Cisplatin markedly impaired renal function and induced tubular injury; meanwhile, AAT significantly reversed these changes. Cisplatin also induced severe oxidative stress and disrupted the balance of NOX isoforms; AAT restored redox homeostasis. Cisplatin upregulated CPT1A/PDK4 and suppressed CPT2, UCP3, PGC1α, and DRP1, inducing maladaptive mitochondrial changes, indicating impaired β-oxidation and defective mitochondrial dynamics; AAT reversed these alterations, restoring normal mitochondrial metabolism. IL-1β, IL-6R, OPN, and F4/80 expression, recovery of the Bax/Bcl-2 ratio, and MAPK activation were reduced, indicating decreased inflammation and apoptosis; profibrotic markers were also reduced. AAT confers multifaceted protection against cisplatin-induced AKI by restoring redox balance, mitochondrial homeostasis, and inflammatory and apoptotic signaling. These findings support AAT as a promising therapeutic agent for preventing cisplatin nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
- Cell and Matrix Research Institute, Kyungpook National University, Daegu 41944, Republic of Korea.
ORCID-Profile: Mina Kim, Jin Han, Ji-Young Choi, Jang-Hee Cho, Sun-Hee Park, Chan-Duck Kim, Yong-Lim Kim, You Hyun Jeon, Jeong-Hoon Lim
Förderung
- Kyungpook National University Hospital
- Biomedical Research Institute grant, Kyungpook National University Hospital
Zitieren
APA
Kim, M., Oh, S. H., Han, J., Ahn, J. S., Oh, E. J., Jung, H. Y., Choi, J. Y., Cho, J. H., Park, S. H., Kim, C. D., Kim, Y. L., Jeon, Y. H., & Lim, J. H. (2026). Alpha-1 Antitrypsin Protects Against Cisplatin-Induced Acute Kidney Injury by Restoring Redox and Mitochondrial Homeostasis. Biomolecules. https://doi.org/10.3390/biom16020222
Vancouver
Kim M, Oh SH, Han J, Ahn JS, Oh EJ, Jung HY, et al. Alpha-1 Antitrypsin Protects Against Cisplatin-Induced Acute Kidney Injury by Restoring Redox and Mitochondrial Homeostasis. Biomolecules. 2026. doi:10.3390/biom16020222
BibTeX
@article{Kim2026,
author = {Kim, Mina and Oh, Se-Hyun and Han, Jin and Ahn, Ji-Sun and Oh, Eun-Joo and Jung, Hee-Yeon and Choi, Ji-Young and Cho, Jang-Hee and Park, Sun-Hee and Kim, Chan-Duck and Kim, Yong-Lim and Jeon, You Hyun and Lim, Jeong-Hoon},
title = {Alpha-1 Antitrypsin Protects Against Cisplatin-Induced Acute Kidney Injury by Restoring Redox and Mitochondrial Homeostasis},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16020222}
}
EUVIMED